Close Menu

University of Pittsburgh

A research collaboration involving several universities has yielded a technique that they said isolates exosomes from biological samples more effectively than incumbent methods.

In Nature this week: bacteriophage evolution varies based on host, lifestyle, and genetic factors; and more.

Through prospective pancreatic ductal adenocarcinoma testing, researchers saw germline mutations in new genes and in cases outside of current germline testing criteria.

The blood-based test is based on three serum biomarkers —matrix metallopeptidase-9, neuron-specific enolase, and vascular cellular adhesion molecule-1.

The researchers noted that the results "highlight the great potential of nanopore sequencing to analyze broad microbial community trends."

The organizations in the consortium will identify, characterize, and catalog human biological molecules affected by physical activity in volunteer biosamples.

Variant data for thousands of Europeans led to seven facial feature-associated sites in the genome, including loci near development or disease-related genes.

The prospective multi-site research study aims to determine the mutation prevalence of pancreatic cancer patients with a hereditary predisposition to the disease.

Gene expression patterns in nearly 150 post-mortem brain samples hinted at age-related changes to the circadian rhythm of transcripts in the human cortex.

Microarrays can detect smaller deletions in genes relevant to diseases like acute lymphoblastic leukemia, offering insight into diagnosis, treatment, and prognosis.

Pages

A new paper says an effort to introduce gene drives into mosquitos altered the genetic makeup of the local mosquitos, but the company behind the project says the paper is flawed.

Virginia's Department of Forensic Science is offering attorneys a course on DNA testing, the Virginian-Pilot reports.

Researchers examine changes in the genomes of emmer wheat populations where the climate has warmed, the BBC reports.

In Cell this week: microinjection of CRISPR-Cas9 enables targeted mutations in Anolis, melanoma proteomic profiling, and more.